New-onset diabetes after kidney transplantation

can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?

  • Santos, Alfonso H Jr
  • Chen, Chao
  • Casey, Michael J
  • Womer, Karl L
  • Wen, Xuerong

  • Division of Nephrology, Hypertension and Renal Transplantation, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA

    Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA

    Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, USA

Correspondence and offprint requests to: Alfonso H. Santos Jr; E-mail: [email protected]

Received July 09, 2017

Nephrology Dialysis Transplantation 33(1):p 177-184, January 01, 2018. | DOI: 10.1093/ndt/gfx281
Copyright © European Renal Association - European Dialysis and Transplant Association 2018. Published by Oxford University Press. All rights reserved.
View full text|Download PDF